Characterising the cardiovascular safety profile of inhaled muscarinic receptor antagonists
Author:
Publisher
European Respiratory Society
Reference74 articles.
1. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019;Eur Respir J,2019
2. Safety considerations with dual bronchodilator therapy in COPD: an update;Drug Saf,2016
3. Association of cardiovascular risk with inhaled long-acting bronchodilators in patients with chronic obstructive pulmonary disease: a nested case-control study;JAMA Intern Med,2018
4. The role of anticholinergics in chronic obstructive pulmonary disease;Am J Med,2004
5. Cardiac effects of current treatments of chronic obstructive pulmonary disease;Lancet Respir Med,2016
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Implications of Cardiopulmonary Risk for the Management of COPD: A Narrative Review;Advances in Therapy;2024-04-25
2. Cardiovascular Events with the Use of Long-Acting Muscarinic Receptor Antagonists: An Analysis of the FAERS Database 2020–2023;Lung;2024-02-06
3. Cardiovascular diseases or type 2 diabetes mellitus and chronic airway diseases: mutual pharmacological interferences;Therapeutic Advances in Chronic Disease;2023-01
4. Comparative studies of dual bronchodilation in COPD;Monaldi Archives for Chest Disease;2021-02-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3